SNT logo

Synektik Spólka Akcyjna Stock Price

WSE:SNT Community·zł2.5b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 48 Fair Values set on narratives written by author

SNT Share Price Performance

zł292.60
79.60 (37.37%)
zł204.19
Fair Value
zł292.60
79.60 (37.37%)
43.3% overvalued intrinsic discount
zł204.19
Fair Value
Price zł292.60
Phetuvov zł204.19

SNT Community Narratives

Fair Value
·
Fair Value zł204.19 43.3% overvalued intrinsic discount

Cardiac marker could be a hit

1users have liked this narrative
0users have commented on this narrative
10users have followed this narrative
SNT logo
Synektik Spólka Akcyjna

Cardiac marker could be a hit

In 5 years, the company should still be thriving, entering new markets and expanding in existing ones. Positive passage of the third stage of testing of a new cardiac marker could help.Read more

View narrative
zł204.19
43.3% overvalued intrinsic discount
Fair Value
Revenue
8.49% p.a.
Profit Margin
13%
Future PE
22x
Price in 2029
zł311.79

Trending Discussion

Updated Narratives

SNT logo

Cardiac marker could be a hit

Fair Value: zł204.19 43.3% overvalued intrinsic discount
10 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Undervalued with solid track record.

2 Risks
4 Rewards

Synektik Spólka Akcyjna Key Details

zł794.9m

Revenue

zł515.6m

Cost of Revenue

zł279.4m

Gross Profit

zł121.4m

Other Expenses

zł157.9m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 05, 2026
18.52
35.14%
19.87%
20.5%
View Full Analysis

About SNT

Founded
2001
Employees
231
CEO
Cezary Kozanecki
WebsiteView website
www.synektik.com.pl

Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and nuclear medicine. It is also involved in development of IT solutions used in radiology, as well as research, produces, and sells radiopharmaceutical products used in diagnostics for oncology. In addition, the company operates a research laboratory for diagnostic imaging systems and a service center for medical equipment. Further, it offers maintenance services for medical equipment, as well as acceptance and specialist tests. The company was founded in 2001 and is based in Warsaw, Poland.

Recent SNT News & Updates

Analysis Article Jan 09

Estimating The Fair Value Of Synektik Spólka Akcyjna (WSE:SNT)

Key Insights The projected fair value for Synektik Spólka Akcyjna is zł258 based on 2 Stage Free Cash Flow to Equity...

Recent updates

No updates